Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

November 01, 2011 (Vol. 31, No. 19)

GEN's 30th Anniversary: Peptide Therapeutics

  • The Peptide Therapeutics Foundation recently reported that 131 peptide drug candidates were in development and 54 additional ones had been approved for marketing. The foundation went on to note that over the past 30 years, peptides have been widely investigated as potential therapies for a number of diseases. Indeed, ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.